n.红细胞生成素

Erythropoietin (EPO) is a hormone produced by the kidneys in response to low oxygen levels in the body.
促红细胞生成素（EPO）是一种由肾脏在体内氧气水平低时产生的激素。
The doctor prescribed erythropoietin injections for my patient with anemia due to chronic kidney disease.
医生为我患有慢性肾病贫血的病人开了促红细胞生成素注射剂。
Erythropoietin therapy has shown promise in improving athletic performance by increasing red blood cell production.
通过增加红细胞生成，促红细胞生成素疗法在提高运动员表现方面显示出前景。
In severe cases of altitude sickness, doctors may administer erythropoietin to boost the production of red blood cells.
在严重高山病情况下，医生可能会使用促红细胞生成素来提升红细胞的生成。
Erythropoietin deficiency can lead to a condition called anemia, characterized by fatigue and pale skin.
促红细胞生成素缺乏可能导致贫血，其特征是疲劳和皮肤苍白。
The monitoring of erythropoietin levels is crucial in managing patients undergoing chemotherapy for cancer.
在管理癌症化疗患者时，监测促红细胞生成素水平至关重要。
Researchers discovered that exercise can stimulate the production of erythropoietin in the body, contributing to increased oxygen-carrying capacity.
研究者发现运动可以刺激体内促红细胞生成素的产生，有助于提高携氧能力。
Hemoglobinopathies, like sickle cell anemia, can reduce erythropoietin production, necessitating medical intervention.
镰状细胞贫血等血红蛋白病会降低促红细胞生成素的产生，需要医疗干预。
Erythropoietin treatments are not without risks, as they can potentially increase the risk of blood clots or high blood pressure.
促红细胞生成素治疗并非没有风险，它们可能增加血栓或高血压的风险。
The use of recombinant erythropoietin in sports medicine is controversial, as it's seen as a form of performance-enhancing drug.
在运动医学中使用重组促红细胞生成素是有争议的，因为它被视为一种提高性能的药物。